Boxer Capital, LLC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$84,809,155
+108231.1%
1,676,7330.0%4.52%
+24.3%
Q2 2023$78,287
+146.1%
1,676,733
+101.7%
3.63%
+132.3%
Q1 2023$31,813
-99.9%
831,4950.0%1.56%
-34.9%
Q4 2022$45,565,926
+60.9%
831,4950.0%2.40%
+50.9%
Q3 2022$28,312,000
+260.3%
831,4950.0%1.59%
+219.7%
Q2 2022$7,858,000
-33.4%
831,4950.0%0.50%
-17.8%
Q1 2022$11,799,000
-32.9%
831,4950.0%0.61%
-11.3%
Q4 2021$17,586,000
-5.4%
831,4950.0%0.68%
+5.2%
Q3 2021$18,584,000
-9.9%
831,4950.0%0.65%
-10.9%
Q2 2021$20,629,000
-14.5%
831,4950.0%0.73%
-11.0%
Q1 2021$24,122,000
+12.4%
831,4950.0%0.82%
+18.6%
Q4 2020$21,453,000
-16.2%
831,4950.0%0.69%
-22.0%
Q3 2020$25,602,000
+146.7%
831,495
+99.6%
0.88%
+94.1%
Q2 2020$10,379,000
+17.5%
416,4950.0%0.46%
-24.3%
Q1 2020$8,830,000
-17.5%
416,495
-13.7%
0.60%
-0.7%
Q4 2019$10,709,000
-2.4%
482,4950.0%0.61%
-23.9%
Q3 2019$10,977,000
+44.5%
482,495
+21.6%
0.80%
+21.9%
Q2 2019$7,597,000396,6950.65%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders